Buy Veracyte Stock | VCYT Stock Price & Latest News | Public
VCYT

Veracyte

$0.00 (0.00%)Today

    About VCYT

    Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulm...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.16
    -0.24
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.11

    Actual EPS
    Q4 2020

    Stats

    Market Cap$2,97B
    Volume31,67k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$51.88
    1 Year Low$13.90
    Open$52.18
    High$52.76
    Low$50.82

    Buy any stock with any amount of money.

    Download the App
    Download the app